Epidemiological game-theory dynamics of chickenpox vaccination in the USA and Israel

Journal of the Royal Society Interface

Volumn 9, Issue 66, 2012, Pages 68-76

  Liu, Jingzhou ^a   Kochin, Beth F ^b   Tekle, Yonas I ^a,c   Galvani, Alison P ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

Chickenpox; Epidemic model; Game theory; Nash equilibrium; Utilitarian vaccination

Indexed keywords

ANIMALS; COSTS; EPIDEMIOLOGY;

CHICKENPOX; EPIDEMIC MODELS; EXTERNAL REGULATIONS; INDIVIDUAL CHOICE; NASH EQUILIBRIUM; TREATMENT COSTS; UTILITARIAN VACCINATION;

GAME THEORY;

ARTICLE; CHICKENPOX; DISEASE SEVERITY; EPIDEMIC; GAME; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; ISRAEL; UNITED STATES; VACCINATION;

EID: 84855435181     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2011.0001     Document Type: Article

References (35)

1. Lenne, X., Domingo, J. D., Gil, A., Ridao, M., Lluch, J. A. & Dervaux, B. 2006 Economic evaluation of varicella vaccination in Spain - results from a dynamic model. Vaccine 24, 6980-6989. (doi:10.1016/j.vaccine.2006.04. 051)
2. Preblud, S. R. 1986 Varicella: complications and costs. Pediatrics 78, 728-735. (Pubitemid 16007075)
3. Meyer, P. A., Seward, J. F., Jumaan, A. O. & Wharton, M. 2000 Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J. Infect. Dis. 182, 383-390. (doi:10.1086/315714)
4. Preblud, S. R. 1981 Age-specific risks of varicella complications. Pediatrics 68, 14-17. (Pubitemid 11061357)
5. Wooten, K. G., Darling, N., Singleton, J. A., Shefer, A. & Cdc 2007 National, state, and local area vaccination coverage among children aged 19-35 months - United States, 2006. JAMA 298, 2475-2476.
6. (Reprinted from MMWR, 56, 880-885, 2007.) (doi:10.1001/jama.298.21.2475)
7. Zhou, F., Harpaz, R., Jumaan, A. O., Winston, C. A. & Shefer, A. 2005 Impact of varicella vaccination on health care utilization. JAMA 294, 797-802. (doi:10.1001/jama.294.7.797)
8. Pinot de Moira, A. & Nardone, A. 2005 Varicella zoster virus vaccination policies and surveillance strategies in Europe. Euro. Surveill. 10, 43-45.
9. Rentier, B. & Gershon, A. A. 2004 Consensus: varicella vaccination of healthy children - a challenge for Europe. Pediatr. Infect. Dis. J. 23, 379-389. (doi:10.1097/01.inf.0000122606.88429.8f)
10. Grotto, I., Balicer, R. D., Smetana, Z., Davidovitch, N., Bar-Zeev, Y., Mendelson, E., Zarka, S. & Huerta, M. 2008 Immunity to varicella zoster virus among young adults: a decline prior to widespread uptake of varicella vaccines. Infection 36, 130-134. (doi:10.1007/s15010-007-7192-7)
11. Adler, A., Herring, E., Babilsky, H., Gazala, E., Cohen, A. & Levy, I. 2007 Parent-dependent barriers to varicella immunization in Israel: the importance of adequate information. Acta Paediatr. 96, 428-431. (doi:10.1111/j.1651-2227.2007.00118.x)
12. Miron, D., Lavi, I., Kitov, R. & Hendler, A. 2005 Vaccine effectiveness and severity of varicella among previously vaccinated children during outbreaks in day-care centers with low vaccination coverage. Pediatr. Infect. Dis. J. 24, 233-236. (doi:10.1097/01.inf.0000154323.20387.82)
13. Barrett, S. 2003 Global disease eradication. J. Eur. Econ. Assoc. 1, 591-600. (doi:10.1162/154247603322391224)
14. Bauch, C. T., Galvani, A. P. & Earn, D. J. D. 2003 Group interest versus self-interest in smallpox vaccination policy. Proc. Natl Acad. Sci. USA 100, 10 564-10 567. (doi:10.1073/pnas.1731324100)
15. Brisson, M., Edmunds, W. J., Gay, N. J., Law, B. & De Serres, G. 2000 Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes. Vaccine 18, 2775-2778. (doi:10.1016/S0264-410X(00)00100-6)
16. Brisson, M., Edmunds, W. J., Gay, N. J., Law, B. & De Serres, G. 2000 Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol. Infect. 125, 651-669. (doi:10.1017/S0950268800004714)
17. Halloran, M. E., Cochi, S. L., Lieu, T. A., Wharton, M. & Fehrs, L. 1994 Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool-children in the United-States. Am. J. Epidemiol. 140, 81-104. (Pubitemid 24205807)
18. Schuette, M. C. & Hethcote, H. W. 1999 Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull. Math. Biol. 61, 1031-1064. (doi:10.1006/bulm.1999.0126)
19. Huse, D. M., Meissner, H. C., Lacey, M. J. & Oster, G. 1994 Childhood vaccination against chickenpox - an analysis of benefits and costs. J. Pediatr. 124, 869-874. (doi:10.1016/S0022-3476(05)83173-7)
20. Lieu, T. A., Cochi, S. L., Black, S. B., Halloran, M. E., Shinefield, H. R., Holmes, S. J., Wharton, M. & Washington, A. E. 1994 Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 271, 375-381. (doi:10.1001/jama.271.5.375)
21. Scuffham, P. A., Lowin, A. V. & Burgess, M. A. 1999 The cost-effectiveness of varicella vaccine programs for Australia. Vaccine 18, 407-415. (doi:10.1016/S0264-410X(99)00261-3)
22. Galvani, A. P., Reluga, T. C. & Chapman, G. B. 2007 Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proc. Natl Acad. Sci. USA 104, 5692-5697. (doi:10.1073/pnas.0606774104)
23. Reluga, T. C., Bauch, C. T. & Galvani, A. P. 2006 Evolving public perceptions and stability in vaccine uptake. Math. Biosci. 204, 185-198. (doi:10.1016/j.mbs.2006.08.015)
24. Brisson, M. & Edmunds, W. J. 2002 The cost-effectiveness of varicella vaccination in Canada. Vaccine 20, 1113-1125. (doi:10.1016/S0264-410X(01)00437- 6)
25. Ginsberg, G. M. & Somekh, E. 2004 Cost containment analysis of childhood vaccination against varicella in Israel. J. Infect. 48, 119-133. (doi:10.1016/S0163-4453(03)00079-3)
26. Galil, K., Brown, C., Lin, F. & Seward, J. 2002 Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr. Infect. Dis. J. 21, 931-934. (doi:10.1097/00006454-200210000-00009)
27. Chaves, S. S., Gargiullo, P., Zhang, J. X., Civen, R., Guris, D., Mascola, L. & Seward, J. F. 2007 Loss of vaccine-induced immunity to varicella over time. N. Engl. J. Med. 356, 1121-1129. (doi:10.1056/NEJMoa064040)
28. Seward, J. F., Zhang, J. X., Maupin, T. J., Mascola, L. & Jumaan, A. O. 2004 Contagiousness of varicella in vaccinated cases: a household contact study. JAMA 292, 704-708. (doi:10.1001/jama.292.6.704)
29. Schmid, D. S. & Jumaan, A. O. 2010 Impact of varicella vaccine on varicella-zoster virus dynamics. Clin. Microbiol. Rev. 23, 202-217. (doi:10.1128/CMR.00031-09)
30. Anderson, R. M. & May, R. M. 1982 Directly transmitted infections diseases: control by vaccination. Science 215, 1053-1060. (doi:10.1126/science. 7063839)
31. Anderson, R. M. & May, R. M. 1991 Infectious diseases of humans: dynamics and control. Oxford, UK: Oxford University Press.
32. Halloran, M. E. 1996 Epidemiologic effects of varicella vaccination. Infect. Dis. Clin. N. Am. 10, 631-655. (doi:10.1016/S0891-5520(05)70318-4)
33. Guess, H. A., Broughton, D. D., Melton, L. J. & Kurland, L. T. 1986 Population-based studies of varicella complications. Pediatrics 78, 723-727. (Pubitemid 16007074)
34. Center for Disease Control and Prevention 2007 Vaccine price list. See http://www.cdc.gov/vaccines/programs/vfc/cdc-vac-price-list.htm.
35. Bauch, C. T. & Earn, D. J. D. 2004 Vaccination and the theory of games. Proc. Natl Acad. Sci. USA 101, 13 391-13 394. (doi:10.1073/pnas. 0403823101)